Effect of Genetic Polymorphisms on the Development of Secondary Failure to Sulfonylurea in Egyptian Patients With Type 2 Diabetes

Therapeutic Advances in Endocrinology and Metabolism - United States
doi 10.1177/2042018811415985
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Causes of the Oral Therapy Secondary Failure in Patients With Diabetes Mellitus Type 2

Scripta Medica
2009English

The Role of MTNR1B Genetic Polymorphisms in Type 2 Diabetes Mellitus

BMC Genomics
BiotechnologyGenetics
2014English

Effect of Cytochrome P450 2c9 Gene Polymorphisms on Individual Sensitivity to Gliclazide in Patients With Type 2 Diabetes Mellitus

HERALD of North-Western State Medical University named after I.I. Mechnikov
2015English

The Cost-Effectiveness of Alogliptin Versus Sulfonylurea as Add-On Therapy to Metformin in Patients With Uncontrolled Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Gliclazide and Bedtime Insulin Are More Efficient Than Insulin Alone for Type 2 Diabetic Patients With Sulfonylurea Secondary Failure

Brazilian Journal of Medical and Biological Research
ImmunologyCell BiologyPharmacologyBiochemistryBiophysicsNeuroscienceMedicineToxicologyPhysiologyPharmaceutics
2001English

Comparison of Antioxidative Effect of Metformin and Combination of Metformin-Sulfonylurea in Type 2 Diabetes Mellitus Patients

Journal of Young Pharmacists
ToxicologyPharmaceuticsPharmacology
2017English

Association of CTLA-4 Polymorphisms With Type 1 Diabetes in the Egyptian Population

J Diabetes Metab
2013English

Genetic Aspects of Hypertension in Patients With Diabetes Mellitus Type 2

Effective Pharmacotherapy
2019English

Genetic Aspects of Hypertension in Patients With Diabetes Mellitus Type 2

Effective Pharmacotherapy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy